Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

AMGN

AMGEN Inc

Dec 06 • 04:00PM ET

272.58

Dollar change -1.75
Percentage change -0.64	%

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	34.90	EPS (ttm)	7.81	Insider Own	0.24%	Shs Outstand	537.50M	Perf Week	-3.64%
Market Cap	145.59B	Forward P/E	13.17	EPS next Y	20.70	Insider Trans	0.00%	Shs Float	536.24M	Perf Month	-15.29%
Income	4.23B	PEG	6.98	EPS next Q	5.04	Inst Own	78.01%	Short Float	1.83%	Perf Quarter	-16.37%
Sales	32.32B	P/S	4.50	EPS this Y	4.96%	Inst Trans	-0.34%	Short Ratio	3.57	Perf Half Y	-10.64%
Book/sh	14.00	P/B	19.46	EPS next Y	5.74%	ROA	4.66%	Short Interest	9.81M	Perf Year	1.20%
Cash/sh	16.87	P/C	16.16	EPS next 5Y	5.00%	ROE	55.72%	52W Range	257.80 - 346.85	Perf YTD	-5.36%
Dividend Est.	9.11 (3.34%)	P/FCF	23.17	EPS past 5Y	-0.22%	ROI	6.57%	52W High	-21.41%	Beta	0.55
Dividend TTM	9.00 (3.30%)	Quick Ratio	0.96	Sales past 5Y	3.42%	Gross Margin	60.22%	52W Low	5.73%	ATR (14)	7.89
Dividend Ex-Date	Nov 18, 2024	Current Ratio	1.32	EPS Y/Y TTM	-44.30%	Oper. Margin	20.14%	RSI (14)	28.93	Volatility	1.87% 2.83%
Employees	26700	Debt/Eq	8.02	Sales Y/Y TTM	21.38%	Profit Margin	13.09%	Recom	2.26	Target Price	329.57
Option/Short	Yes / Yes	LT Debt/Eq	7.55	EPS Q/Q	62.38%	Payout	68.24%	Rel Volume	1.44	Prev Close	274.33
Sales Surprise	0.06%	EPS Surprise	5.79%	Sales Q/Q	23.11%	Earnings	Oct 30 AMC	Avg Volume	2.75M	Price	272.58
SMA20	-5.62%	SMA50	-11.34%	SMA200	-10.78%	Trades		Volume	3,965,046	Change	-0.64%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290

Show Previous Ratings

Dec-07-24 10:39AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
10:00AM	BLINCYTO (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) (PR Newswire)
Dec-06-24 06:07AM	AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B (BioPharma Dive)
03:14AM	Why Amgen Inc. (AMGN) Is Among the Best Affordable Stocks to Buy Right Now (Insider Monkey)
Dec-05-24 09:00AM	AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA (PR Newswire)
07:28AM	Loading…
07:28AM	Is Amgen Still a Top Dividend Stock? (Motley Fool)
Dec-02-24 04:00PM	AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
08:00AM	This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip? (Motley Fool)
07:43AM	Analyst Report: Amgen Inc. (Morningstar Research)
Nov-30-24 07:18PM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
07:00AM	Eli Lilly and Novo Nordisks Obesity Moat Just Got Stronger (The Wall Street Journal)
06:20AM	Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy? (Motley Fool)
Nov-29-24 04:30PM	AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE (PR Newswire)
02:06PM	Wide Trading Range For Amgen Stock Makes This Option Shine (Investor's Business Daily)
09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
04:28AM	Loading…
04:28AM	Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? (Motley Fool)
Nov-27-24 07:10AM	Amgens MariTide shows up to 20% average weight loss in Phase 2 study (TipRanks)
03:57AM	Why Amgen's Weight Loss Result Is a Win for Eli Lilly (Motley Fool)
Nov-26-24 06:45PM	Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond (CNBC TV)
05:16PM	Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment (Investor's Business Daily)
04:51PM	S&P 500 Gains and Losses Today: NRG Energy Stock Surges After Analyst Upgrade (Investopedia)
04:20PM	Dow Jones, S&P 500 At New High After Fed Minutes; Dell, Workday, CrowdStrike Report (Live Coverage) (Investor's Business Daily)
03:45PM	Analyst Report: Amgen Inc. (Morningstar Research)
02:03PM	Amgen share price plummets despite Phase II weight loss success (Clinical Trials Arena)
01:32PM	Chart of the Day: Amgen (CNBC TV)
01:28PM	Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations (Investopedia)
01:26PM	Amgen Stock Dives After Weight-Loss Drug Data. Heres What to Know. (Barrons.com)
01:04PM	Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment (Investor's Business Daily)
01:01PM	Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed (Quartz)
12:03PM	Top Stock Movers Now: Amgen, Best Buy, JM Smucker, and More (Investopedia)
11:56AM	Loading…
11:56AM	Amgen stock slips as obesity drug study disappoints Wall Street (Yahoo Finance Video)
11:31AM	Amgen Falls as Weight-Loss Shot Results Disappoint Street (Bloomberg)
10:44AM	Cramer's Stop Trading: Amgen (CNBC TV)
10:17AM	Amgen Obesity Drug Cut Weight In Closely Watched Study (The Wall Street Journal)
09:54AM	Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound (Investor's Business Daily)
09:33AM	Stocks Open Mixed. Amgen Is Dragging on the Dow. (Barrons.com)
09:16AM	Amgen shows 20% weight loss in once-monthly injectable MariTide (Yahoo Finance)
08:54AM	Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test (Investor's Business Daily)
08:36AM	Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau (Benzinga)
08:32AM	Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know. (Barrons.com)
08:31AM	Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau (CNBC TV)
08:11AM	Amgen falls after obesity study results (Investing.com)
07:05AM	AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY (PR Newswire)
07:00AM	AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM (PR Newswire)
Nov-22-24 04:17PM	RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried? (Investor's Business Daily)
09:40AM	Why Amgen (AMGN) is a Top Value Stock for the Long-Term (Zacks)
08:00AM	Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry? (Investor's Business Daily)
Nov-21-24 06:14AM	Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares (Reuters)
04:40AM	Amgen picks prolific biotech founder Chang as new top scientist (BioPharma Dive)
02:00AM	Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop (Barrons.com)
Nov-20-24 04:00PM	AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT (PR Newswire)
Nov-19-24 03:59PM	Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage. (Investor's Business Daily)
Nov-18-24 09:44AM	Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
12:40AM	Analyst Report: Amgen Inc. (Morningstar Research)
Nov-16-24 09:00AM	The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue? (Yahoo Finance)
08:45AM	2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious (Motley Fool)
Nov-14-24 04:00PM	AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024 (PR Newswire)
01:53PM	5 Healthcare Stocks to Buy in a Beaten-Up Sector (Barrons.com)
10:15AM	2 Dividend Stocks to Buy Hand Over Fist in November (Motley Fool)
09:54AM	Citi initiates coverage on 5 new biotech stocks (Investing.com)
08:34AM	Amgen speaks out about bone density concerns with obesity drug (Clinical Trials Arena)
Nov-13-24 04:06PM	Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? (Investor's Business Daily)
01:59PM	Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density (Benzinga)
01:56PM	Trade Tracker: Joe Terranova sells Amgen and buys XBI (CNBC TV)
09:49AM	Amgen Rebounds, Shaking Off 'Overdone' Fears Tied To Its Weight-Loss Shot (Investor's Business Daily)
06:15AM	Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing (BioPharma Dive)
05:24AM	Amgen dismisses bone density concerns related to its new weight-loss drug (Reuters)
05:00AM	AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA (PR Newswire)
Nov-12-24 06:26PM	Amgen sinks as Cantor flags issues with obesity drug (CNBC TV) -7.14%
04:43PM	S&P 500 Gains and Losses Today: Mosaic Stock Slumps After Earnings Miss (Investopedia)
04:38PM	Amgen Drops 7% After A 'Big Unknown Risk' Rattles Its Monthly Obesity Shot (Investor's Business Daily)
Nov-10-24 07:00AM	As Trump Readies a Reset of Antitrust Policy, Look to These Sectors for Deals (The Wall Street Journal)
Nov-08-24 04:00PM	AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
09:52AM	AstraZeneca and Amgens Tezspire succeeds in Phase III nasal polyps trial (Pharmaceutical Technology)
09:32AM	Analyst Report: Amgen Inc. (Morningstar Research)
08:47AM	AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis (Benzinga)
02:00AM	TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (PR Newswire)
Nov-05-24 09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Nov-04-24 06:03PM	Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now? (Insider Monkey)
07:00AM	Big Pharmas Obesity Bonanza Faces New Tests (The Wall Street Journal)
Nov-01-24 08:00AM	The Art of Valuation: Discovering Amgen Inc's Intrinsic Value (GuruFocus.com)
01:03AM	Decoding Amgen Inc (AMGN): A Strategic SWOT Insight (GuruFocus.com)
Oct-31-24 04:15PM	Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO (Investor's Business Daily)
01:48PM	Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight (Pharmaceutical Technology)
01:39PM	Q3 2024 Amgen Inc Earnings Call (Thomson Reuters StreetEvents)
09:28AM	Analyst Report: Amgen Inc. (Morningstar Research)
03:21AM	Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ... (GuruFocus.com)
Oct-30-24 08:15PM	Amgen (AMGN) Q3 2024 Earnings Call Transcript (Motley Fool)
05:30PM	Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Amgen (AMGN) Beats Q3 Earnings Estimates (Zacks)
04:09PM	Amgen: Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	Amgen posts higher profit, obesity data on track for late this year (Reuters)
04:01PM	AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Oct-29-24 04:11PM	Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen. (Investor's Business Daily)
Oct-26-24 04:30AM	2 Reliable Dividend Stocks You Can Buy and Hold Forever (Motley Fool)
Oct-25-24 04:00PM	AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND (PR Newswire)
09:15AM	Ahead of Amgen (AMGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
06:35AM	GSK invests $800M in manufacturing; Amgen sets small discount for Eylea biosimilar (BioPharma Dive)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	May 03 '24	Sale	313.09	2,117	662,802	9,883	May 03 07:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience